Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

Table 2 Patient characteristics for the 2 trials n (%)

	Placebo group	Active group
Subjects, n	287	292
Age (yr), mean ± SD	45.3 ± 14.03	44.4 ± 14.79
Subject weight (kg), mean ± SD	64.6 ± 12.37	65.8 ± 13.75
Subject height (cm), mean ± SD	164.3 ± 7.75	164.9 ± 8.19
Subject BMI (kg/m²), mean ± SD	23.9 ± 3.93	24.1 ± 4.53
Heart rate (bpm), mean ± SD	70.2 ± 9.10	70.6 ± 9.08
Female	244 (85.0)	245 (83.9)
Smoker	65 (22.6)	75 (25.7)
IBS-C	134 (46.7)	130 (44.5)
IBS-C with an abdominal pain/discomfort score ≥ 2 at baseline	111 (38.7)	111 (38.0)
IBS-D	55 (19.2)	56 (19.2)
IBS-M	96 (33.4)	103 (35.3)

BMI: Body mass index; IBS: Irritable bowel syndrome.